liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
LONG TERM COST-EFFECTIVENESS ANALYSIS OF TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROMES FROM A BRAZILIAN PUBLIC HEALTHCARE PERSPECTIVE BASED ON DATA FROM THE PLATO TRIAL in VALUE IN HEALTH, vol 14, issue 7, pp A380-A380
University of Sao Paulo.
AstraZeneca.
Östergötlands Läns Landsting.
AstraZeneca RandD.
Show others and affiliations
2011 (English)In: VALUE IN HEALTH, Wiley-Blackwell / Elsevier , 2011, Vol. 14, no 7, A380-A380 p.Conference paper, Published paper (Refereed)
Abstract [en]

n/a

Place, publisher, year, edition, pages
Wiley-Blackwell / Elsevier , 2011. Vol. 14, no 7, A380-A380 p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-75296ISI: 000299107100775OAI: oai:DiVA.org:liu-75296DiVA: diva2:505894
Conference
ISPOR 14TH ANNUAL EUROPEAN CONGRESS
Available from: 2012-02-27 Created: 2012-02-24 Last updated: 2012-03-02

Open Access in DiVA

No full text

By organisation
Östergötlands Läns Landsting
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 29 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf